Recent findings from a nationally representative survey found that only 44% of U.S. jails provide medications to treat opioid use...

The webinar focused on how the JCOIN Clinical Research Centers (Research Hubs) empower people with lived experience (PWLE) and the...

Xylazine is a non-opioid sedative not approved for human use that is increasingly found as an adulterant in the illicit drug supply and...

Findings from JCOIN’s University of Kentucky Research Center and Methodology and Advanced Analytics Resource Center (MAARC) The number of...

The transition from incarceration back into the community is a particularly vulnerable time, especially for individuals with substance...

Findings from JCOIN’s Coordination and Translation Center (CTC) A recent study published in the journal Victims & Offenders  explores the...

The U.S. Department of Health and Human Services (HHS) approved Illinois, Kentucky, Oregon, Utah, and Vermont to provide healthcare...

Findings from JCOIN’s Yale HIV Research Center The intersection of substance use disorders (SUD) and human immunodeficiency virus (HIV)...

In April 2024, the Substance Abuse & Mental Health Services Administration (SAMHSA) issued a final rule on regulations regarding opioid...

JCOIN Study on Barriers and Facilitators within Opioid Intervention Courts that Impact Substance Use Disorder Treatment

Opioid Use Disorder Best Practices for Corrections highlights 10 essential strategies that jails and prisons can use to address the...

While previous studies examine the availability of medications for opioid use disorder (MOUD) in jails and the barriers to using these...

Findings from JCOIN’s Coordination and Translation Center (CTC) The growing rates of substance use and overdose deaths have significantly...

Findings from JCOIN’s Methodology and Advanced Analytics Resource Center (MAARC) A study recently published in Preventive Medicine...

The Addiction Forum Policy hosted a webinar discussing the recent findings from the Massachusetts Justice Community Opioid Innovation...

Findings from JCOIN’s Yale School of Medicine Clinical Research Center In a study by the Yale School of Medicine and the NYU Grossman...

Xylazine is a non-opioid tranquilizer used in veterinary medicine and is increasingly found as an adulterant in the illicit drug supply....

Findings from JCOIN’s Massachusetts Clinical Research Center Diversion of medication for opioid use disorder (MOUD) treatment is often...

Reduced Risk Factors, Increased Protective Factors for Justice-Involved Clients Findings from JCOIN’s Coordination and Translation Center...

The Justice Department’s Bureau of Justice Assistance (BJA), a program office within the Office of Justice Programs (OPJ), collaborated...